title: Ramucirumab in metastatic renal cell carcinoma: the sex, race, and age issues.
authors.affiliation: The Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei, China.
authors.forename: Fengxia
authors.initials: F
authors.lastname: Liu
authors.forename: Qingyi
authors.initials: Q
authors.lastname: Liu
authors.forename: Guiying
authors.initials: G
authors.lastname: Wang
authors.forename: Weikuan
authors.initials: W
authors.lastname: Gu
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors; D040301:Vascular Endothelial Growth Factor Receptor-2